SUMMARY Jejunal mucosal crypts were examined in jejunal biopsies from eight children with acute lvmphoblastic leukaemia who had recently received methotrexate treatment. By comparison with biopsies from children under investigation for suspected malabsorption crypt mitosis was significantly reduced and showed a negative correlation with the dose of methotrexate given prior to biopsy. The three major cell types were studied under light and transmission electron microscopy. Gut endocrine cells were unaffected by therapy and immature crypt enterocytes showed only patchy degenerative abnormalities. By contrast a number of Paneth cells showed striking structural alterations with vacuolar dilatation of the cytoplasm. The extent of this correlated with the time since methotrexate treatment rather than its dose and may have been a functional response rather than of a toxic nature.
Methotrexate (MTX) plays an important role in the maintenance of disease remission in children with acute lymphoblastic leukaemia (ALL). The enterotoxic effect of the folate antagonists was recognised in the experimental animal prior to its clinical use' and was an important limiting factor in early treatment schedules.2 In addition to a direct toxic effect upon mature enterocytes,34 MTX may also produce villus abnormalities indirectly by interference with cell generation in the crypts. Blocked mitotic activity was a consistent feature in animal studies"6 and has been described in jejunal biopsies after a single intravenous dose of MTX in adults with psoriasis.' Apart from these observations the influence of MTX on individual cell populations in the small intestinal crypt has not been previously studied in detail.
Jejunal biopsies from children with ALL were examined under light and electron microscopy and the morphological features of the major cell types are described.
Patients and methods
Thirteen jejunal biopsies were studied; eight were from children with ALL receiving MTX treatment, whose ages ranged from 2 6 to 12 5 yr and five were Accepted for publication 24 March 1982 from patients being investigated for diarrhoea and/ or failure to thrive (control group) that were subsequently found to be normal. The In the MTX-treated cases degenerative changes were evident in a number of immature enterocytes with varying degrees of intracellular vacuolation and in some cases complete degeneration and loss of cytoplasmic structure. These changes were however of patchy distribution and seen in a minority of crypts even after four doses of MTX (Table & Fig .2 ). Under electron microscopy the majority appeared normal with maintenance of intercellular junctions and contact with the basement membrane (Fig. 3) . Degenerative changes were not present in control biopsies. Endocrine cells appeared to be unaltered in treated cases and did not differ from those in control biopsies. (Fig. 4) .
Paneth cells after MTX showed the most marked * A .
'---50 The interpretation of changes in mitotic index is limited by the static nature of the method and stathmokinetic techniques are required to study crypt cell kinetics in detail. However in view of the S phase action of MTX it is reasonable to assume that any reduction in mitotic index is due to a reduction in cell proliferation rather than a decrease in mitotic duration. Both of these could result in similar numbers of mitotic figures at any particular time of counting. The early reduction in mitotic activity, evident three hours after a single dose was consistent with the threshold serum drug concentration for inhibition of DHFR, estimated to be about 10-'M.13 In the majority of children on maintenance therapy for ALL such a serum concentration is reached within 20 min of an oral dose of MTX (15 mg/M2). 14 The correlation shown between the decrease in mitotic activity and the cumulative dose of MTX may account for the difference in the incidence of oral toxicity associated with a five-day course of therapy as opposed to a single weekly dose. After a single dose a number of cells remain in mitosis which permits rapid repopulation of epithelial surfaces, whereas prolonged complete inhibition associated with several daily doses results in the failure to replace shed cells and consequent mucosal degeneration. Buccal mucosal ulceration is seen in less than 10% of children receiving weekly MTX compared with as many as 80% on five-day schedules. '5 Gut endocrine cells appeared to be resistant to the effects of MTX which might have been expected in view of their slow rate of turnover. 6 The abnormalities seen in the Paneth cells, which also have a slow turnover time (02 wk),'6 were however quite unexpected. These cells may be influenced by mechanisms other than a blockade of the synthetic phase, although RNA and protein synthesis are usually only disrupted with higher dose therapy.
Paneth cell vacuolation has been described after x irradiation but this was an early effect accompanied by more generalised crypt cell damage.'7 8 The possibility therefore arises that the cellular alterations were a functional response rather than of a toxic nature.
The role of the Paneth cell has long been an area of debate and functions have been suggested in relation to enzyme secretion' "'2 local nutrient secretion2' and the control of crypt cell growth.22 Although crypt cell damage and reduced cell numbers have been reported in the experimental animal after treatment with a number of cytotoxic agents23-26 detailed cell morphology has not been considered. In a study of jejunal biopsies after a single intravenous dose of MTX in adults with psoriasis Trier reported generalised patchy necrosis of all cell types.3 Such abnormalities may have been related to the high peak serum drug concentration associated with this route of administration. Other reports of cytotoxic damage to the human small gut do not specifically describe Paneth cell features.27 8 The possibility that the changes were secondary to a nutritional deficit such as zinc deficiency must be considered. Striking Paneth cell abnormalities have been described in acrodermatitis enteropathica29 and this condition has been reported in a child receiving cytotoxic therapy.-" Although serum zinc concentrations were not estimated in this study no case had clinical signs of such a deficiency. The relation between the extent of abnormalities and recent MTX treatment indicates that they represented a short term effect. Furthermore the characteristic features of zinc deficiency-secretory granule degeneration and cytoplasmic inclusions, were not seen.
It could be postulated that the cytoplasmic vacuolation was a response to the inhibition of crypt enterocyte mitosis. It is likely that a feedback mechanism exists between villus enterocytes and crypt cell production which involves one of more trophic agents," although the precise nature of this remains unclear. Could the changes in the Paneth cell cytoplasm be due to increased synthetic activity in an attempt to increase cell turnover in response to reduced villus cell numbers? Some support for this hypothesis comes from the observation that a group of patients with severe villus atrophy unresponsive to gluten withdrawal were deficient in Paneth cells"2. The jejunal biopsies also showed reduced crypt depth and a uniform decrease in mitotic activity. Although these abnormalities were suggested to be related to a local nutritive activity of Paneth cells,2' they could also have been due to a defect in the crypt regulatory mechanism. 
